Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102–e7.

Article  CAS  PubMed  Google Scholar 

Carfì A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603–5.

Article  PubMed  PubMed Central  Google Scholar 

Mahase E. Covid-19: what do we know about “long covid”? BMJ. 2020;370:m2815.

Article  PubMed  Google Scholar 

Elneima O, Hurst JR, Echevarria C, Quint JK, Walker S, Siddiqui S, et al. Long-term impact of COVID-19 hospitalisation among individuals with pre-existing airway diseases in the UK: a multicentre, longitudinal cohort study—PHOSP-COVID. ERJ Open Res. 2024;10(4).

Ghafari M, Hall M, Golubchik T, Ayoubkhani D, House T, MacIntyre-Cockett G, et al. Prevalence of persistent SARS-CoV‑2 in a large community surveillance study. Nature. 2024;626(8001):1094–101.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alipoor SD, Mirsaeidi M. SARS-CoV‑2 cell entry beyond the ACE2 receptor. Mol Biol Rep. 2022;49(11):10715–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Donald J, Bilasy SE, Yang C, El-Shamy A. Exploring the complexities of long COVID. Viruses. 2024;16(7).

Vojdani A, Vojdani E, Saidara E, Maes M. Persistent SARS-coV‑2 infection, EBV, HHV‑6 and other factors may contribute to inflammation and autoimmunity in long COVID. Viruses. 2023;15(2).

Maes M, Almulla AF, Tang X, Stoyanova K, Vojdani A. From human herpes virus‑6 reactivation to autoimmune reactivity against tight junctions and neuronal antigens, to inflammation, depression, and chronic fatigue syndrome due to long COVID. J Med Virol. 2024;96(8):e29864.

Article  CAS  PubMed  Google Scholar 

Wang EY, Mao T, Klein J, Dai Y, Huck JD, Jaycox JR, et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595(7866):283–8.

Article  CAS  PubMed  Google Scholar 

Kratzer B, Gattinger P, Trapin D, Ettel P, Körmöczi U, Rottal A, et al. Differential decline of SARS-CoV-2-specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID-19. Allergy. 2024;79(9):2482–501.

Article  CAS  PubMed  Google Scholar 

Zang C, Hou Y, Schenck EJ, Xu Z, Zhang Y, Xu J, et al. Identification of risk factors of long COVID and predictive modeling in the RECOVER EHR cohorts. Commun Med. 2024;4(1):130.

Article  PubMed  PubMed Central  Google Scholar 

Lundberg-Morris L, Leach S, Xu Y, Martikainen J, Santosa A, Gisslén M, et al. Covid-19 vaccine effectiveness against post-covid-19 condition among 589 722 individuals in Sweden: population based cohort study. BMJ. 2023;383:e76990.

Article  PubMed  PubMed Central  Google Scholar 

Marra AR, Kobayashi T, Callado GY, Pardo I, Gutfreund MC, Hsieh MK, et al. The effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions: a systematic literature review and meta-analysis of the latest research. Antimicrob Steward Healthc Epidemiol. 2023;3(1):e168.

Article  PubMed  PubMed Central  Google Scholar 

Xie Y, Choi T, Al-Aly Z. Association of treatment with Nirmatrelvir and the risk of post-COVID-19 condition. JAMA Intern Med. 2023;183(6):554–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vogel JM, Pollack B, Spier E, McCorkell L, Jaudon TW, Fitzgerald M, et al. Designing and optimizing clinical trials for long COVID. Life Sci. 2024;355:122970.

Article  CAS  PubMed  Google Scholar